Sector Charles River Laboratories International, Inc. Deutsche Boerse AG
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 196.10 EUR | -1.78% |
|
+0.33% | +14.11% |
| 07-20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |  |
| 07-13 | BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220 | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.14% | -0.85% | +4.79% | +14.65% | +4.17% | -1.20% | +11.73% | -17.93% | +206.12% | 47.74B | |
| -2.24% | +1.92% | +0.98% | +39.64% | +130.83% | +385.05% | +630.47% | +556.17% | - | 39.98B | |
| +1.40% | +6.40% | +18.07% | +10.56% | +8.77% | +13.38% | +57.74% | +22.73% | +1,106.94% | 36.23B | |
| +13.94% | +19.15% | +27.10% | +48.28% | +7.78% | +21.98% | +8.18% | -0.10% | +223.92% | 35.59B | |
| -0.73% | +2.78% | +6.93% | -8.69% | +2.91% | +4.65% | +41.16% | -18.11% | +147.26% | 27.91B | |
| +0.40% | +1.06% | -2.42% | +12.26% | - | - | - | - | - | 16.71B | |
| -3.12% | +8.15% | +8.33% | +35.50% | +1.66% | +27.59% | +129.42% | +233.63% | - | 16.45B | |
| +2.39% | -3.63% | -0.64% | +11.34% | +9.81% | -0.35% | +10.34% | -31.85% | +102.06% | 13.21B | |
| +6.79% | +8.46% | +6.11% | +74.63% | -1.09% | -3.62% | -25.41% | -19.42% | +131.40% | 12.93B | |
| +0.63% | +0.60% | +1.51% | +30.77% | +22.55% | +22.61% | -13.87% | -39.13% | +160.39% | 11.16B | |
| -3.89% | -7.87% | +28.76% | +12.57% | -9.63% | +90.88% | +503.77% | +251.53% | +2,484.32% | 11.1B | |
| -0.08% | +0.01% | +1.22% | +55.16% | +77.76% | +228.69% | +530.20% | - | - | 10.08B | |
| -2.71% | +1.18% | +43.31% | +28.61% | +32.68% | +25.73% | +45.86% | -54.49% | - | 9.54B | |
| -1.18% | +4.44% | -31.88% | -23.44% | -30.10% | +30.90% | +43.64% | +52.05% | +89.51% | 9.25B | |
| -3.53% | -4.41% | -1.81% | +22.47% | +36.43% | +131.84% | +379.06% | +82.59% | - | 9.05B | |
| -6.33% | -2.83% | -9.76% | -10.63% | +0.36% | +399.51% | +2,178.27% | +25.61% | - | 8.8B | |
| -4.23% | -2.36% | -8.32% | +49.72% | +80.49% | +93.26% | +66.78% | +109.20% | -2.47% | 8.79B | |
| +0.94% | +1.91% | +12.27% | +38.91% | +56.68% | +148.12% | +628.65% | +200.68% | - | 8.72B | |
| +2.92% | +4.45% | +7.28% | +11.00% | -10.68% | -22.44% | -18.91% | -26.71% | +57.97% | 8.5B | |
| Average | +0.08% | +1.34% | +5.89% | +23.86% | +23.41% | +88.70% | +289.28% | +78.03% | +427.95% | 17.99B | |
| Weighted average by Cap. | +1.03% | +2.10% | +7.92% | +23.76% | +26.63% | +85.73% | +219.59% | +97.28% | +430.46% |
- Stock Market
- Stocks
- CRL Stock
- RV6 Stock
- Sector Charles River Laboratories International, Inc.
Select your edition
All financial news and data tailored to specific country editions
